Company / Gross Profit per Share
Innoviva, Inc. Gross Profit per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$4.91
FY2025
5-year range
$3.56 / $4.91
FY2023-FY2025
Trend
+4.9%
vs FY2024
Sector context
#16 of 29
Health Care
What the data says
At $4.91, Innoviva, Inc.'s gross profit per share ranks #16 of 29 in the Health Care sector. Improved from $3.56 to $4.91 over the past 2 years.
Based on SEC 10-K filings.
4.91 in FY2025.
Improved from $3.56 to $4.91 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#16 of 29 in Health CareTop 55% of 29This company $4.91 Sector average $8.11
▼
-39.4% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 4.9% year-over-year.
- Ranks #16 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.91 | +4.9% |
| FY2024 | $4.68 | +31.6% |
| FY2023 | $3.56 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026